{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06043310",
            "orgStudyIdInfo": {
                "id": "PRO40920"
            },
            "organization": {
                "fullName": "Medical College of Wisconsin",
                "class": "OTHER"
            },
            "briefTitle": "Estrogen and Microvascular Function",
            "officialTitle": "Sex-specific Effects of Continuous Estrogen on Human in Vivo Microvascular Function",
            "therapeuticArea": [
                "Other"
            ],
            "study": "estrogen-and-microvascular-function"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-12",
            "studyFirstSubmitQcDate": "2023-09-12",
            "studyFirstPostDateStruct": {
                "date": "2023-09-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Julie K. Freed",
                "investigatorTitle": "Executive Vice Chair",
                "investigatorAffiliation": "Medical College of Wisconsin"
            },
            "leadSponsor": {
                "name": "Medical College of Wisconsin",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to learn how long-term use of estrogen affects blood vessels in healthy adults who were assigned male at birth.\n\nParticipants will:\n\n* give one blood draw of 5 mL\n* have a camera placed under the tongue to take pictures of blood vessels\n* have 2 laser Doppler microdialysis catheters placed on the forearm to monitor blood vessels before and after local drug infusion\n\nResearchers will compare blood vessel function of those who take estrogen supplements to those who do not."
        },
        "conditionsModule": {
            "conditions": [
                "Estrogen",
                "Cardiovascular Diseases",
                "Microvasculature"
            ],
            "keywords": [
                "Transgender",
                "Hormone Replacement Therapy"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "CROSS_SECTIONAL"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "whole blood"
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "AMAB + continuous estrogen",
                    "description": "Identify as assigned male at birth (AMAB) who have had continuous estrogen treatment for a minimum of 1 year.",
                    "interventionNames": [
                        "Drug: N\u03c9-nitro-L-arginine methyl ester (L-NAME)",
                        "Drug: Acetylcholine",
                        "Drug: Sodium Nitroprusside"
                    ]
                },
                {
                    "label": "AMAB - continuous estrogen",
                    "description": "Identify as assigned male at birth (AMAB) who have not had continuous estrogen treatment for a minimum of 1 year.",
                    "interventionNames": [
                        "Drug: N\u03c9-nitro-L-arginine methyl ester (L-NAME)",
                        "Drug: Acetylcholine",
                        "Drug: Sodium Nitroprusside"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "N\u03c9-nitro-L-arginine methyl ester (L-NAME)",
                    "description": "L-NAME will be infused locally through microdialysis catheters.",
                    "armGroupLabels": [
                        "AMAB + continuous estrogen",
                        "AMAB - continuous estrogen"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Acetylcholine",
                    "description": "ACh will be infused locally through microdialysis catheters.",
                    "armGroupLabels": [
                        "AMAB + continuous estrogen",
                        "AMAB - continuous estrogen"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Sodium Nitroprusside",
                    "description": "SNP will be infused locally through microdialysis catheters.",
                    "armGroupLabels": [
                        "AMAB + continuous estrogen",
                        "AMAB - continuous estrogen"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in blood vessel dilation",
                    "description": "Cutaneous vascular conductance in response to acetylcholine, L-NAME, and sodium nitroprusside infusions will be calculated as percentage of cardiovascular conductance.",
                    "timeFrame": "2 hours"
                },
                {
                    "measure": "Change in Perfused Vessel Density",
                    "description": "Total vessel density (TVD) will be calculated using the DeBacker Score manual analysis on all images that have a minimum microcirculation image quality score (MIQS) of 10. Perfused vessel density (PVD) will be calculated by multiplying total vessel density (TVD) x proportion of perfused vessels (PPV%).",
                    "timeFrame": "0.5 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults aged 18-60 years\n* Identify as assigned male at birth (AMAB) +/- continuous estrogen treatment for a minimum of 1 year.\n* Blood pressure \\<140/ \\< 90 mmHg\n* No more than 1 cardiovascular risk factor\n\nExclusion Criteria:\n\n* BMI \\>35\n* Medications that could alter cardiovascular control\n* Rash, skin disease, or pigmentation disorders\n* Anemia\n* Kidney Disease\n* Known skin allergies\n* Smoking or tobacco use within last 6 months\n* Coronary Artery Disease\n* \\> 1 cardiovascular risk factor\n* Hypertension\n* Diabetes\n* Hypercholesterolemia\n* Hyperlipidemia\n* Bleeding disorders\n* Use of anti-coagulants\n* Allergies to study drugs\n* Erectile dysfunction medication in the past 6 months\n* Use of topical/non-topical steroids in last 6 months\n* Internal mouth sores",
            "sex": "MALE",
            "minimumAge": "18 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "Community sample",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Shona Hang",
                    "role": "CONTACT",
                    "phone": "414-955-2348",
                    "email": "shang@mcw.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Froedtert Hospital",
                    "status": "RECRUITING",
                    "city": "Wauwatosa",
                    "state": "Wisconsin",
                    "zip": "53226",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shona Hang",
                            "role": "CONTACT",
                            "phone": "414-955-2348",
                            "email": "shang@mcw.edu"
                        },
                        {
                            "name": "Julie Freed, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.04946,
                        "lon": -88.00759
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009599",
                    "term": "Nitroprusside"
                },
                {
                    "id": "D000000109",
                    "term": "Acetylcholine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000020030",
                    "term": "Nitric Oxide Donors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018679",
                    "term": "Cholinergic Agonists"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M12536",
                    "name": "Nitroprusside",
                    "asFound": "Hormone Receptor Positive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3473",
                    "name": "Acetylcholine",
                    "asFound": "Hyaluronidase",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8116",
                    "name": "Estrogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M21308",
                    "name": "NG-Nitroarginine Methyl Ester",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M12507",
                    "name": "Nitric Oxide",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T1",
                    "name": "Arginine",
                    "asFound": "Healthy controls",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "NiOxD",
                    "name": "Nitric Oxide Donors"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}